Genomic structure and transcriptional regulation of the human somatostatin receptor type 2

Molecular and Cellular Endocrinology

Volumn 157, Issue 1-2, 1999, Pages 75-85

  Petersenn, Stephan ^a   Rasch, Anja C ^a   Presch, Stefanie ^a   Beil, Frank U ^a   Schulte, Heinrich M ^a  

^a UNIVERSITY OF HAMBURG   (Germany)

Author keywords

G protein coupled receptor; Regulation; Somatostatin receptor; Structure

Indexed keywords

RECEPTOR SUBTYPE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR;

ARTICLE; BINDING SITE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE STRUCTURE; HORMONAL REGULATION; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; POLYADENYLATION; PRIORITY JOURNAL; PROMOTER REGION; TRANSCRIPTION REGULATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; CLONING, MOLECULAR; CODON, INITIATOR; COS CELLS; GENE EXPRESSION REGULATION; GENOMIC LIBRARY; GLUCOCORTICOIDS; HAPLORHINI; HUMANS; MOLECULAR SEQUENCE DATA; PITUITARY NEOPLASMS; PLACENTA; PROMOTER REGIONS (GENETICS); RATS; RECEPTORS, SOMATOSTATIN; SEQUENCE ANALYSIS, DNA; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 0032727943     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0303-7207(99)00161-6     Document Type: Article

References (36)

1. Berelowitz M., Xu Y., Song J., Bruno J.F. Regulation of somatostatin receptor mRNA expression. Ciba Found. Symp. 190:1995;111-122.
2. Bruno J.F., Xu Y., Berelowitz M. Somatostatin regulates somatostatin receptor subtype mRNA expression in GH3 cells. Biochem. Biophys. Res. Commun. 202:1994;1738-1743.
3. Caron P., Buscail L., Beckers A., Esteve J.P., Igout A., Hennen G., Susini C. Expression of somatostatin receptor SST4 in human placenta and absence of octreotide effect on human placental growth hormone concentration during pregnancy. J. Clin. Endocrinol. Metab. 82:1997;3771-3776.
4. Elsholtz H.P., Albert V.R., Treacy M.N., Rosenfeld M.G. A two-base change in a POU factor-binding site switches pituitary-specific to lymphoid-specific gene expression. Genes Dev. 4:1990;43-51.
5. Faisst S., Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res. 20:1992;3-26.
6. Gillies G. Somatostatin: the neuroendocrine story. Trends Pharmacol. Sci. 18:1997;87-95.
7. Greenwood M.T., Robertson L.A., Patel Y.C. Cloning of the gene encoding human somatostatin receptor 2: sequence analysis of the 5′-flanking promoter region. Gene. 159:1995;291-292.
8. Hinkle P.M., Perrone M.H., Schonbrunn A. Mechanism of thyroid hormone inhibition of thyrotropin-releasing hormone action. Endocrinology. 108:1981;199-205.
9. Imagawa M., Chiu R., Karin M. Transcription factor AP-2 mediates induction by two different signal-transduction pathways: protein kinase C and cAMP. Cell. 51:1987;251-260.
10. Ingraham H.A., Chen R.P., Mangalam H.J., Elsholtz H.P., Flynn S.E., Lin C.R., Simmons D.M., Swanson L., Rosenfeld M.G. A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell. 55:1988;519-529.
11. James R.A., Sarapura V.D., Bruns C., Raulf F., Dowding J.M., Gordon D.F., Wood W.M., Ridgway E.C. Thyroid hormone-induced expression of specific somatostatin receptor subtypes correlates with involution of the TtT-97 murine thyrotrope tumor. Endocrinology. 138:1997;719-724.
12. Kimura N., Tomizawa S., Arai K.N. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Endocrinology. 139:1998;1573-1580.
13. Kraus J., Woltje M., Schonwetter N., Hollt V. Alternative promoter usage and tissue specific expression of the mouse somatostatin receptor 2 gene. FEBS Lett. 428:1998;165-170.
14. O'Carroll A.M., Raynor K., Lolait S.J., Reisine T. Characterization of cloned human somatostatin receptor SSTR5. Mol. Pharmacol. 46:1994;291-298.
15. Patel Y.C., Greenwood M., Kent G., Panetta R., Srikant C.B. Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem. Biophys. Res. Commun. 192:1993;288-294.
16. Patel Y.C., Greenwood M.T., Panetta R., Demchyshyn L., Niznik H., Srikant C.B. The somatostatin receptor family. Life Sci. 57:1995;1249-1265.
17. Petersenn S., Rasch A.C., Heyens M., Schulte H.M. Structure and regulation of the human growth hormone-releasing hormone receptor gene. Mol. Endocrinol. 12:1998;233-247.
18. Presky D.H., Schonbrunn A. Somatostatin pretreatment increases the number of somatostatin receptors in GH4C1 pituitary cells and does not reduce cellular responsiveness to somatostatin. J. Biol. Chem. 263:1988;714-721.
19. Pscherer A., Dorflinger U., Kirfel J., Gawlas K., Ruschoff J., Buettner R., Schule R. The helix-loop-helix transcription factor SEF-2 regulates the activity of a novel initiator element in the promoter of the human somatostatin receptor II gene. EMBO J. 15:1996;6680-6690.
20. Raynor K., Murphy W.A., Coy D.H., Taylor J.E., Moreau J.P., Yasuda K., Bell G.I., Reisine T. Cloned somatostatin receptors: identification of subtype-selective peptides and demonstration of high affinity binding of linear peptides. Mol. Pharmacol. 43:1993;838-844.
21. Reichlin S. Somatostatin. N. Engl. J. Med. 309:1983;1495-1501.
22. Reichlin S. Somatostatin. N. Engl. J. Med. 309:1983;1556-1563.
23. Reisine T. Somatostatin receptors. Am. J. Physiol. 269:1995;G813-G820.
24. Reubi J.C., Laissue J.A. Multiple actions of somatostatin in neoplastic disease. Trends Pharmacol. Sci. 16:1995;110-115.
25. Rohrer S.P., Birzin E.T., Mosley R.T., Berk S.C., Hutchins S.M., Shen D.M., Xiong Y., Hayes E.C., Parmar R.M., Foor F., Mitra S.W., Degrado S.J., Shu M., Klopp J.M., Cai S.J., Blake A., Chan W.W.S., Pasternak A., Yang L., Patchett A.A., Smith R.G., Chapman K.T., Schaeffer J.M. Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science. 282:1998;737-740.
26. Rossowski W.J., Coy D.H. Specific inhibition of rat pancreatic insulin or glucagon release by receptor-selective somatostatin analogs. Biochem. Biophys. Res. Commun. 205:1994;341-346.
27. Schonbrunn A. Glucocorticoids down-regulate somatostatin receptors on pituitary cells in culture. Endocrinology. 110:1982;1147-1154.
28. Senaris R.M., Lago F., Dieguez C. Gonadal regulation of somatostatin receptor 1, 2 and 3 mRNA levels in the rat anterior pituitary. Brain Res. Mol. Brain Res. 38:1996;171-175.
29. Takumi T., Lodish H.F. Rapid cDNA cloning by PCR screening. Biotechniques. 17:1994;443-444.
30. Vale W., Vaughan J., Yamamoto G., Spiess J., Rivier J. Effects of synthetic human pancreatic (tumor) GH releasing factor and somatostatin, triiodothyronine and dexamethasone on GH secretion in vitro. Endocrinology. 112:1983;1553-1555.
31. Viguerie N., Esteve J.P., Susini C., Logsdon C.D., Vaysse N., Ribet A. Dexamethasone effects on somatostatin receptors in pancreatic acinar AR4-2J cells. Biochem. Biophys. Res. Commun. 147:1987;942-948.
32. Wegner M., Drolet D.W., Rosenfeld M.G. POU-domain proteins: structure and function of developmental regulators. Curr. Opin. Cell Biol. 5:1993;488-498.
33. Xu Y., Berelowitz M., Bruno J.F. Dexamethasone regulates somatostatin receptor subtype messenger ribonucleic acid expression in rat pituitary GH4C1 cells. Endocrinology. 136:1995;5070-5075.
34. Xu Y., Song J., Berelowitz M., Bruno J.F. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Endocrinology. 137:1996;5634-5640.
35. Xu Y., Berelowitz M., Bruno J.F. Characterization of the promoter region of the human somatostatin receptor subtype 2 gene and localization of sequences required for estrogen-responsiveness. Mol. Cell. Endocrinol. 139:1998;71-77.
36. Yamada Y., Post S.R., Wang K., Tager H.S., Bell G.I., Seino S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc. Natl. Acad. Sci. USA. 89:1992;251-255.